Literature DB >> 24633670

Endoscopic and pathologic findings associated with clinical outcomes of melanoma in the upper gastrointestinal tract.

Ji Yong Ahn1, Hee Sang Hwang, Young Soo Park, Hyeong Ryul Kim, Hwoon-Yong Jung, Jin-Ho Kim, Seung Eun Lee, Min A Kim.   

Abstract

BACKGROUND: Melanoma that involves the upper gastrointestinal (GI) tract is rare and studies relating to endoscopic and pathologic findings with clinical outcomes are lacking. We reviewed the gross and microscopic patterns of the upper GI tract in primary and metastatic melanoma, and examined their association with clinical outcomes.
METHODS: Twenty-nine cases of primary esophageal (n = 19) and metastatic gastric and/or duodenal melanoma (n = 10) that were detected during upper GI endoscopy between 1995 and 2011 were retrospectively analyzed.
RESULTS: Three types of gross patterns were recognized-nodular pattern in 7 cases, mass-forming pattern in 18 cases, and flat pigmented pattern in 4 cases. In primary esophageal melanoma, 13 patients (68.4 %) underwent surgery and 9 received palliative therapy. Of all cases, 22 patients (75.9 %) died of disease progression; the median overall survival period was 12 months (interquartile range [IQR] 4.5-24.5 months), and from recognition of upper GI tract melanoma the median overall survival period was 9 months (IQR 3.5-17.0 months). In primary esophageal cases, skin melanoma stage better discriminated the patients with good prognosis than the esophageal cancer stage. The flat pigmented gross pattern proved to be a good prognostic factor in primary and metastatic GI tract melanomas (p = 0.016 and p = 0.046, respectively).
CONCLUSIONS: Melanoma of the GI tract is a highly aggressive disease with a poor prognosis, both in primary and metastatic cases. However, in primary esophageal melanoma, careful inspection of the mucosa during endoscopic examination followed by surgical resection may result in extended survival.

Entities:  

Mesh:

Year:  2014        PMID: 24633670     DOI: 10.1245/s10434-014-3637-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  4 in total

1.  Clinicopathological Features, Staging Classification, and Clinical Outcomes of Esophageal Melanoma: Evaluation of a Pooled Case Series.

Authors:  Haiyan Sun; Ningning Zhu; Lei Gong; Lan Lan; Zhentao Yu; Zhanyu Pan
Journal:  Front Oncol       Date:  2022-07-01       Impact factor: 5.738

2.  Primary malignant melanoma of the esophagus: A retrospective analysis of clinical features, management, and survival of 76 patients.

Authors:  Xuan Wang; Yan Kong; Zhihong Chi; Xinan Sheng; Chuanliang Cui; Lili Mao; Bin Lian; Bixia Tang; Xieqiao Yan; Lu Si; Jun Guo
Journal:  Thorac Cancer       Date:  2019-03-12       Impact factor: 3.500

3.  Suppression of CDCA3 inhibits prostate cancer progression via NF‑κB/cyclin D1 signaling inactivation and p21 accumulation.

Authors:  Peng Gu; Minhao Zhang; Jin Zhu; Xiaoliang He; Dongrong Yang
Journal:  Oncol Rep       Date:  2021-12-31       Impact factor: 3.906

4.  Clinical characteristics and treatment outcomes of primary malignant melanoma of esophagus: a single center experience.

Authors:  Tae-Se Kim; Byung-Hoon Min; Yang Won Min; Hyuk Lee; Poong-Lyul Rhee; Jae J Kim; Jun Haeng Lee
Journal:  BMC Gastroenterol       Date:  2022-03-29       Impact factor: 3.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.